Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?

We report a young male patient who developed plasma cell myeloma/plasmacytoma 11 years after having received an allogeneic hematopoietic cell transplantation for AML. The patient received a second transplantation from the same donor without immunosuppression and developed graft-versus-host disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakanay, Sule Mine, Serbest, Esin, Dalva, Klara, Kuzu, Isinsu, Beksac, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395258/
https://www.ncbi.nlm.nih.gov/pubmed/22811719
http://dx.doi.org/10.1155/2012/319530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395258/
https://www.ncbi.nlm.nih.gov/pubmed/22811719
http://dx.doi.org/10.1155/2012/319530

Ejemplares similares